Sarepta Therapeutics, Inc. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Sarepta Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q2 2024.
  • Sarepta Therapeutics, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$701K, a 99.5% increase year-over-year.
  • Sarepta Therapeutics, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was $38M.
  • Sarepta Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$268M, a 50.1% increase from 2022.
  • Sarepta Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$536M, a 16.6% decline from 2021.
  • Sarepta Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$460M, a 18.5% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $38M -$701K +$133M +99.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 -$94.8M $34.9M +$173M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-01
Q4 2023 -$268M $24.6M +$131M Oct 1, 2023 Dec 31, 2023 10-K 2024-02-28
Q3 2023 -$399M -$20.8M +$111M +84.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-01
Q2 2023 -$510M -$134M +$77.6M +36.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 -$587M -$138M -$51.2M -58.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-01
Q4 2022 -$536M -$107M -$1.02M -0.96% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-28
Q3 2022 -$535M -$131M -$96.9M -281% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 -$438M -$211M -$43.6M -26% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 -$395M -$86.9M +$65M +42.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
Q4 2021 -$460M -$106M +$64.9M +38% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-28
Q3 2021 -$525M -$34.5M +$103M +74.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-02
Q2 2021 -$627M -$168M -$29.2M -21.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-02
Q1 2021 -$598M -$152M -$33.8M -28.7% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 -$564M -$171M +$59.5M +25.8% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-01
Q3 2020 -$624M -$137M -$13.5M -10.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 -$610M -$138M +$137M +49.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-04
Q1 2020 -$747M -$118M -$41.6M -54.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-05
Q4 2019 -$706M -$230M -$90.9M -65.2% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-01
Q3 2019 -$615M -$124M -$53.5M -76.3% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-01
Q2 2019 -$561M -$275M -$172M -166% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-01
Q1 2019 -$389M -$76.4M -$45.6M -149% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-01
Q4 2018 -$344M -$139M -$116M -502% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-26
Q3 2018 -$227M -$70.1M -$24.2M -52.7% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-26
Q2 2018 -$203M -$103M -$40.1M -63.3% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-26
Q1 2018 -$163M -$30.7M +$8.51M +21.7% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-26
Q4 2017 -$172M -$23.1M +$65.2M +73.8% Oct 1, 2017 Dec 31, 2017 10-K 2019-02-28
Q3 2017 -$237M -$45.9M +$10.6M +18.8% Jul 1, 2017 Sep 30, 2017 10-K 2019-02-28
Q2 2017 -$248M -$63.3M -$1.24M -2% Apr 1, 2017 Jun 30, 2017 10-K 2019-02-28
Q1 2017 -$246M -$39.2M +$20.5M +34.3% Jan 1, 2017 Mar 31, 2017 10-K 2019-02-28
Q4 2016 -$267M -$88.4M -$23.9M -37.1% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-01
Q3 2016 -$243M -$56.5M -$4.77M -9.22% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-01
Q2 2016 -$238M -$62.1M -$20M -47.5% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-01
Q1 2016 -$218M -$59.7M +$2.16M +3.49% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-01
Q4 2015 -$220M -$64.5M -$19.7M -44.1% Oct 1, 2015 Dec 31, 2015 10-K 2017-02-28
Q3 2015 -$200M -$51.8M -$18.1M -53.7% Jul 1, 2015 Sep 30, 2015 10-K 2017-02-28
Q2 2015 -$182M -$42.1M -$11.8M -39.1% Apr 1, 2015 Jun 30, 2015 10-K 2017-02-28
Q1 2015 -$171M -$61.9M -$36.7M -146% Jan 1, 2015 Mar 31, 2015 10-K 2017-02-28
Q4 2014 -$134M -$44.7M -$11.9M -36.1% Oct 1, 2014 Dec 31, 2014 10-K 2016-02-25
Q3 2014 -$122M -$33.7M -$8.74M -35.1% Jul 1, 2014 Sep 30, 2014 10-K 2016-02-25
Q2 2014 -$113M -$30.3M -$13.2M -77.2% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-25
Q1 2014 -$100M -$25.1M -$9.71M -63% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-25
Q4 2013 -$90.3M -$32.8M -$22.5M -217% Oct 1, 2013 Dec 31, 2013 10-K 2015-02-26
Q3 2013 -$67.8M -$24.9M -$18M -261% Jul 1, 2013 Sep 30, 2013 10-K 2015-02-26
Q2 2013 -$49.8M -$17.1M -$11.5M -207% Apr 1, 2013 Jun 30, 2013 10-K 2015-02-26
Q1 2013 -$38.2M -$15.4M -$8.54M -124% Jan 1, 2013 Mar 31, 2013 10-K 2015-02-26
Q4 2012 -$29.7M -$10.4M -$1.37M -15.2% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-03
Q3 2012 -$28.3M -$6.91M +$4.37M +38.7% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-03
Q2 2012 -$32.7M -$5.56M +$4.57M +45.1% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-03
Q1 2012 -$37.3M -$6.87M -$1.34M -24.3% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-03
Q4 2011 -$35.9M -$9M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-15
Q3 2011 -$11.3M -$7.47M -197% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-15
Q2 2011 -$10.1M -$2.46M -32.1% Apr 1, 2011 Jun 30, 2011 10-K 2013-03-15
Q1 2011 -$5.53M Jan 1, 2011 Mar 31, 2011 10-K 2013-03-15
Q3 2010 -$3.8M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-08
Q2 2010 -$7.67M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.